Breast Cancer: Clinical Trials

8,996 trials for Breast Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4460 completed, 1361 unknown, 1166 recruiting, 713 terminated. 2873 Not applicable, 2189 Phase 2, 1046 Phase 1, 859 Phase 3, 176 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2873Completed 1444, Recruiting 417, Unknown 403, Active not recruiting 195, Not yet recruiting 161, Terminated 144, Withdrawn 85, Enrolling by invitation 15, Suspended 9
Phase 22189Completed 1004, Terminated 317, Unknown 306, Recruiting 249, Active not recruiting 133, Withdrawn 90, Not yet recruiting 85, Suspended 4, Enrolling by invitation 1
Phase 11046Completed 527, Terminated 141, Recruiting 120, Unknown 94, Active not recruiting 74, Withdrawn 57, Not yet recruiting 27, Suspended 5, Enrolling by invitation 1
Phase 3859Completed 460, Unknown 129, Recruiting 87, Active not recruiting 65, Terminated 63, Not yet recruiting 31, Withdrawn 21, Suspended 2, Enrolling by invitation 1
Phase 4176Completed 86, Unknown 37, Recruiting 21, Not yet recruiting 14, Terminated 9, Withdrawn 5, Active not recruiting 4
Early Phase 1128Completed 70, Recruiting 17, Unknown 12, Withdrawn 12, Terminated 11, Not yet recruiting 4, Enrolling by invitation 2

Follow Breast Cancer: new trials by email Literature Review of Breast Cancer trials Research Report on Breast Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Feasibility Trial of a Culturally Tailored Resilience Intervention for Underserved Breast Cancer Survivors
BRIGHT Resilience Intervention, BRIGHT Survivorship Resource Booklet - Breast Cancer, Cancer Survivorship
Not applicableNot yet recruitingUniversity College Dublin802029-10-012026-11-12
Application of Multimodal MRI-based Radiomics in Histological Grading and Prognostic Assessment of Breast Cancer
DCE-MRI - Breast Cancer, Breast Cancer With Low to Intermediate HER2 Expression
Not yet recruitingHao Xu4002028-01-012026-02-05
Gut Microbiome Changes During Abemaciclib Therapy in Breast Cancer
Resistant Potato Starch, Placebo control - Breast Cancer, HER-2 Positive Breast Cancer
Not applicableNot yet recruitingUniversity of Vermont Medical Center122027-10-012026-02-12
DESIR. Evaluation of the Pre-therapeutic Activity of Dihydropyrimidine dEShydrogenase (DPD) in Patients With Cancer and/or Renal Failure
blood sampling, Blood sampling - Renal Impairment, Digestive Cancers
Not yet recruitingCentre Hospitalier Universitaire de Besancon7422027-10-012026-11-02
Developing and Testing the Efficacy of AI-Chatbot-Based
AIAI-Chatbot CalmMindRecoveryJourney delivering BMS-MC therapy - Breast Cancer
Not applicableNot yet recruitingNational Taiwan University Hospital682027-08-012026-08-27
EmpowerHer: Hybrid Digital Intervention for Breast Cancer Survivors
EmpowerHer Hybrid Program - Breast Cancer, Cancer Survivors
Not applicableNot yet recruitingUniversity of Valencia1472027-07-012026-06-30
Multi-4SCAR-T Therapy Targeting Breast Cancer
4SCAR T cells - Breast Cancer
Phase 1 / Phase 2Not yet recruitingShenzhen Geno-Immune Medical Institute1002027-06-012026-11-02
Early Intervention
Juzo Compression Sleeve and Glove, Compression Sleeve Sensor - Breast Cancer, Breast Cancer Treatment Related Lymphedema
Not applicableNot yet recruitingMassachusetts General Hospital402027-05-012026-07-13
Role of Artificial Intelligence in Breast Cancer Screening Via Mammography
Transpara software - Breast Cancer
Not applicableNot yet recruitingCentre Antoine Lacassagne12222027-01-312026-10-20
Assessment of Biosignature Classification of DCIS for RadioTherapy Benefit Post Lumpectomy (ABCD RT)
Radiation Therapy, Standard of Care Radiation Therapy, No Intervention - Breast Cancer
Phase 3Not yet recruitingNRG Oncology52702027-01-302026-09-30
Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer
Neoadjuvant Chemotherapy, Radiation Therapy, MRI - Breast Cancer, HER2-positive Breast Cancer
Phase 1 / Phase 2Not yet recruitingOhio State University Comprehensive Cancer Center842027-01-152026-11-09
Patient-Centered Clinical Trial Navigation: Addressing Gender Disparity in Clinical Trial Participation
Navigation Intervention, Usual Care - Breast Cancer
Not applicableNot yet recruitingMedical College of Wisconsin452027-01-152026-11-18
De-escalation of Axillary Dissection for Node-positive Breast Cancer
TAD, ALND - Breast Cancer by AJCC V8 Anatomic Stage, Breast Cancer
Not applicableNot yet recruitingUniversity of Nebraska202027-01-152026-11-18
Implementing a Digital Alcohol Intervention to Raise Women's Awareness of Alcohol-related Breast Cancer Risk During Routine Screening Visits
Sobriety Digital Intervention - Breast Cancer, Alcohol Drinking
Not applicableNot yet recruitingUniversity of Miami362027-01-042026-10-20
Remotely Supervised Exercise During Chemotherapy in Women With Breast Cancer
Intervention Group - Breast Cancer
Not applicableNot yet recruitingRiga Stradins University602027-01-012026-07-21
Strategies to Decentralize Breast Ultrasound in Rwanda
Teleultrasound with Philips Lumify ultrasound probes and Reacts software, Asynchronous virtual feedback - Breast Cancer, Early Detection of Cancer
Not applicableNot yet recruitingBrigham and Women's Hospital17922027-01-012026-06-02
Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases
Trastuzumab Deruxtecan, Stereotactic Radiosurgery - Breast Cancer, HER2-positive Breast Cancer
Phase 1Not yet recruitingBaptist Health South Florida202027-01-012026-10-01
SOLIS: Single-Dose Radiotherapy With Omission of Lumpectomy for Intact Small Breast Cancers
Stereotactic Radiation Therapy, Endocrine Therapy - Breast Cancer, Early-Stage Breast Carcinoma
Not applicableNot yet recruitingRenaissance Institute of Precision Oncology and Radiosurgery302027-01-012026-09-28
Screening and the Future of Enhanced MRI for Early Breast Cancer Detection
Breast MRI Screening, Questionnaires - Breast Cancer Detection, Breast Cancer
Not applicableNot yet recruitingRadboud University Medical Center26282027-01-012026-10-16
ctDNA-Guided Intraventricular Therapy for CNS Malignancies
CSF ctDNA-Guided Clinical Management - Leptomeningeal Disease, Glioblastoma
Not applicableNot yet recruitingAlireza Mansouri772027-01-012026-07-08

Showing 20 of 8996. Sign in to see all of them.

Narrower conditions

Breast Neoplasms (8996)  ·  Neoplasms (411)  ·  Lung Neoplasms (398)  ·  Ovarian Neoplasms (389)  ·  Prostatic Neoplasms (363)  ·  Colorectal Neoplasms (346)  ·  Neoplasm Metastasis (260)  ·  Triple Negative Breast Neoplasms (217)  ·  Carcinoma, Non-Small-Cell Lung (213)  ·  Motor Activity (210)  ·  Pancreatic Neoplasms (208)  ·  Colonic Neoplasms (201)  ·  Head and Neck Neoplasms (175)  ·  Melanoma (175)  ·  Breast Neoplasms, Male (167)

Broader conditions

Skin and Connective Tissue Diseases (8996)  ·  Skin Diseases (8991)  ·  Neoplasms by Site (8988)  ·  Breast Diseases (8948)  ·  Neoplasms (8585)  ·  Pathological Conditions, Signs and Symptoms (1171)  ·  Urogenital Diseases (819)  ·  Urogenital Neoplasms (765)  ·  Genital Diseases (747)  ·  Neoplasms by Histologic Type (733)  ·  Pathologic Processes (713)  ·  Digestive System Diseases (689)  ·  Digestive System Neoplasms (674)  ·  Gastrointestinal Diseases (627)  ·  Female Urogenital Diseases and Pregnancy Complications (602)

Interventions

Cyclophosphamide (428)  ·  Trastuzumab (394)  ·  Docetaxel (361)  ·  Paclitaxel (346)  ·  Letrozole (236)  ·  Capecitabine (234)  ·  Doxorubicin (227)  ·  Tamoxifen (189)  ·  Carboplatin (184)  ·  Radiotherapy (165)  ·  Epirubicin (162)  ·  Fulvestrant (159)  ·  Anastrozole (158)  ·  Bevacizumab (125)  ·  Surveys and Questionnaires (116)

Sponsors

Memorial Sloan Kettering Cancer Center (214)  ·  Fudan University (157)  ·  M.D. Anderson Cancer Center (142)  ·  Hoffmann-La Roche (135)  ·  Dana-Farber Cancer Institute (118)  ·  AstraZeneca (115)  ·  National Cancer Institute (NCI) (109)  ·  Mayo Clinic (76)  ·  Alliance for Clinical Trials in Oncology (73)  ·  Novartis Pharmaceuticals (73)  ·  UNC Lineberger Comprehensive Cancer Center (67)  ·  Case Comprehensive Cancer Center (58)  ·  Stanford University (57)  ·  Massachusetts General Hospital (52)  ·  Washington University School of Medicine (52)

Countries

United States (3826)  ·  China (1018)  ·  France (707)  ·  Canada (549)  ·  Italy (504)  ·  Spain (457)  ·  United Kingdom (440)  ·  Germany (335)  ·  South Korea (304)  ·  Belgium (292)  ·  Netherlands (244)  ·  Turkey (Türkiye) (235)  ·  Australia (214)  ·  Brazil (191)  ·  Taiwan (184)

Top investigators

Norman Wolmark, MD (30)  ·  Edith A. Perez, MD (18)  ·  Biyun Wang, Professor (15)  ·  Dimitris Mavrudis, MD (15)  ·  James N. Ingle, MD (14)  ·  Dawn Hershman, MD (13)  ·  Mothaffar Rimawi, MD (13)  ·  Carol J Fabian, MD (11)

Results publications

PMID 38979716, PMID 34037241, PMID 29522361, PMID 22508812, PMID 39606939, PMID 40207789, PMID 40443562, PMID 18355913, PMID 22649152, PMID 25071111, PMID 26348120, PMID 26438146, PMID 27432417, PMID 28898379, PMID 41170811, PMID 15894097, PMID 21796368, PMID 21880792, PMID 22198468, PMID 23871490, PMID 25439688, PMID 26101239, PMID 30207593, PMID 30711522, PMID 32101663, PMID 32580883, PMID 32840419, PMID 33326894, PMID 33736679, PMID 33853037, PMID 33856137, PMID 35594464, PMID 37302395, PMID 37338729, PMID 38153568, PMID 38335467, PMID 38598571, PMID 40421669, PMID 12165639, PMID 12393820, PMID 12473512, PMID 15172146, PMID 16157940, PMID 16360786, PMID 16546506, PMID 16598749, PMID 16758122, PMID 16783576, PMID 17236771, PMID 17273752

NIH funding

2023 (38), 2008 (32), P30CA043703 (27), 2005 (26), 2014 (26), 2025 (26), P30CA033572 (24), 2016 (23), U10CA032102 (23), 2015 (22), 2017 (21), 2019 (21), 2018 (20), P30CA068485 (19), 2009 (18)